|
Greetings AVP Partners,
The time has come to enroll or re-enroll in the Adult Vaccine Program!
Based on feedback to previous years’ AVP provider agreement, the team here at DOH has been hard at work modernizing the AVP provider agreement to ensure it meets providers’ needs. Going forward, the AVP provider agreement will be conveniently located in Redcap. Using Recap will streamline the enrollment process, allow providers to save their work and return later, and more easily make updates to agreements as needed.
The 2023-2024 AVP provider agreement is due August 14, 2023.
Please note: A link to request routine vaccines will ONLY be sent to providers who have an agreement on file for their facility by the deadline of August 14, 2023.
COVID-19 vaccines will transition to the commercial marketplace in fall 2023. Most Americans will continue to pay nothing out-of-pocket for the COVID-19 vaccine due to their insurance coverage. However, 25 million uninsured adults will lose access to affordable COVID-19 vaccines. To address this, HHS announced the Bridge Access Program for COVID-19 Vaccines and Treatment – a public/ private partnership as a temporary measure to prevent the loss of under- and uninsured adults’ access to COVID-19 vaccines and treatments at no-cost after commercialization.
The Bridge Program is temporary, beginning in the Fall of 2023.
Bridge Access Program COVID-19 vaccines will be provided through the Adult Vaccine Program. In order to request COVID-19 vaccines for uninsured/ underinsured adults, enroll in the Adult Vaccine Program by August 14, 2023.
-
For enrolled COVID-19 providers, all COVID-19 vaccine ordering will be turned off in the Washington Immunization Information System (WAIIS) at 4 PM PST on Wednesday, August 2nd. Please order sufficient vaccine to ensure you have adequate supply to last until commercialization, anticipated to happen in early fall. Updated vaccine recommendations for all age groups are expected in mid to late September and we expect that commercial ordering will open shortly afterwards.
- Depots will not be permitted under the Bridge Access Program
As additional information becomes available, we will continue to keep you informed.
-
2. Eligibility documentation: Eligibility documentation will be required for all patients receiving AVP vaccine. Eligibility documentation can be completed electronically in the patient’s medical record, in the IIS, or in a forthcoming paper eligibility screening form.
-
3. Site visits will be required for providers newly enrolled in AVP due to new federal guidelines. Providers who were previously enrolled in AVP will not need a site visit at this time. Additional details to come.
These changes will be added to the Adult Vaccine Program Provider Manual soon.
|
